6976 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Acepodia, Inc. operates as a clinical-stage biotechnology company and it develops cell therapies to treat cancer. It designed enhanced cell therapy approaches by applying Antibody-Cell Conjugation (ACC), ?d2 T2, and oNK Cells technology. The company was founded by Patrick Yuhmin Yang and Hsiao Sonny on February 15, 2017 and is headquartered in New Taipei, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
6976 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company